This is a preview of subscription content, log in via an institution to check access.
References
Paul, E. & Carroll, M.C. SAP-less chromatin triggers systemic lupus erythematosus. Nature Med. 5, 607–608 (1999).
Bickerstaff, M.C.M. et al. Serum amyloid P component controls chromatin degradation and prevents anti-nuclear autoimmunity. Nature Med. 5, 694–697 (1999).
Botto, M. et al. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nature Med. 3, 855–859 (1997).
Togashi, S. et al. Serum amyloid P component enhances induction of murine amyloidosis. Lab. Invest. 77, 525–531 (1997).
Hawkins, P.N., Tennent, G.A., Woo, P. & Pepys, M.B. Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis. Clin. Exp. Immunol. 84, 308–316 (1991).
Pepys, M.B. et al. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc. Natl. Acad. Sci. USA 91, 5602–5606 1994).
Pepys, M.B., Lanham, J.G. & de Beer, F.C. in Clinics in the Rheumatic Diseases (ed. Hughes, G.R.V.) 91–103 (W.B. Saunders, Eastbourne, UK, 1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pepys, M. Serum amyloid P component (not Serum Amyloid Protein). Nat Med 5, 852–853 (1999). https://doi.org/10.1038/11272
Issue Date:
DOI: https://doi.org/10.1038/11272
- Springer Nature America, Inc.